高分辨率CT、18F-FDG和18F-NaF PET纵向监测动脉粥样硬化的临床前评价

IF 8.6 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Mikayla Tamboline, Jeffrey Collins, William Jackson, Wenduo Gu, Matthew Worssam, Paul Cheng, John David, Richard Taschereau, Arion F. Chatziioannou, Simon Jackson, Shili Xu, Oluwatayo F. Ikotun
{"title":"高分辨率CT、18F-FDG和18F-NaF PET纵向监测动脉粥样硬化的临床前评价","authors":"Mikayla Tamboline, Jeffrey Collins, William Jackson, Wenduo Gu, Matthew Worssam, Paul Cheng, John David, Richard Taschereau, Arion F. Chatziioannou, Simon Jackson, Shili Xu, Oluwatayo F. Ikotun","doi":"10.1007/s00259-025-07276-1","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Rationale</h3><p>Detection of atherosclerosis is essential to the management and prevention of life-threatening cardiovascular events. Although non-invasive imaging modalities, such as <sup>18</sup>F-sodium fluoride (<sup>18</sup>F-NaF), <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) PET, and CT, visualize distinct hallmarks of atherosclerosis, there has yet to be a singular multi-cohort interrogation of their strengths and limitations. Thus, we focused on identifying the optimal approach for visualizing atherosclerosis at different stages of disease progression.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>In this study, 6-week-old, male, ApoE deficient mice (<i>Apoe</i><sup>−/−</sup>) were placed on a high cholesterol diet for 12–20 weeks to induce calcific atherosclerotic disease. Age-matched, male, wildtype (WT) C57BL/6 mice fed with regular chow served as the control group. Mice were imaged at 12, 15, 18, and 20 weeks after starting their respective diets. To follow the progression of calcified atherosclerotic lesions, at each time point, in vivo<i>,</i> <sup>18</sup>F-NaF microPET/CT images were acquired 1 h and 3 h post tracer i.v. injection. In a separate cohort, in vivo <sup>18</sup>F-FDG PET/CT images were acquired at 3 and 5 h post tracer i.v. injection to follow inflammation as a result of progressive atherosclerotic lesion formation. High-resolution microCT images were acquired for all mice to visualize aorta calcification. After each imaging session, a subset (<i>n</i> = 3) was euthanized from each group and histological analysis of the aorta was performed to confirm disease progression.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>In this comparative study, within the same cohort, <sup>18</sup>F-NaF PET detected atherosclerotic calcification earlier than microCT. At both 1 and 3 h post-injection (p.i.), calcified lesions were clearly detected by <sup>18</sup>F-NaF with a six-fold higher signal in <i>Apoe</i><sup>-/-</sup> compared to WT mice. Interestingly, <sup>18</sup>F-NaF signal peaked at week 18, whereas aortic CT signal progressively increased with a 13-, 16-, and 29-fold at 15, 18, and 20 weeks, respectively. <sup>18</sup>F-FDG arortic accumulation at weeks 12 and 15, were significantly greater in <i>Apoe</i> <sup>−/−</sup> mice than WT control when images were acquired at 5 h but not at 3 h p.i.. In contrast to histological analysis, at ≥ 16 weeks where inflammation is significantly elevated, <sup>18</sup>F-FDG was equivalent in <i>Apoe</i><sup>−/−</sup> and WT control mice and significantly reduced with disease progression.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Our results show that <sup>18</sup>F-NaF PET and <sup>18</sup>F-FDG PET are sensitive imaging modalities for the early detection of atherosclerotic lesions. However, both <sup>18</sup>F-NaF PET and high-resolution microCT prove to be effective methods for monitoring late-stage and progressive disease.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"7 1","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis\",\"authors\":\"Mikayla Tamboline, Jeffrey Collins, William Jackson, Wenduo Gu, Matthew Worssam, Paul Cheng, John David, Richard Taschereau, Arion F. Chatziioannou, Simon Jackson, Shili Xu, Oluwatayo F. Ikotun\",\"doi\":\"10.1007/s00259-025-07276-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Rationale</h3><p>Detection of atherosclerosis is essential to the management and prevention of life-threatening cardiovascular events. Although non-invasive imaging modalities, such as <sup>18</sup>F-sodium fluoride (<sup>18</sup>F-NaF), <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) PET, and CT, visualize distinct hallmarks of atherosclerosis, there has yet to be a singular multi-cohort interrogation of their strengths and limitations. Thus, we focused on identifying the optimal approach for visualizing atherosclerosis at different stages of disease progression.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>In this study, 6-week-old, male, ApoE deficient mice (<i>Apoe</i><sup>−/−</sup>) were placed on a high cholesterol diet for 12–20 weeks to induce calcific atherosclerotic disease. Age-matched, male, wildtype (WT) C57BL/6 mice fed with regular chow served as the control group. Mice were imaged at 12, 15, 18, and 20 weeks after starting their respective diets. To follow the progression of calcified atherosclerotic lesions, at each time point, in vivo<i>,</i> <sup>18</sup>F-NaF microPET/CT images were acquired 1 h and 3 h post tracer i.v. injection. In a separate cohort, in vivo <sup>18</sup>F-FDG PET/CT images were acquired at 3 and 5 h post tracer i.v. injection to follow inflammation as a result of progressive atherosclerotic lesion formation. High-resolution microCT images were acquired for all mice to visualize aorta calcification. After each imaging session, a subset (<i>n</i> = 3) was euthanized from each group and histological analysis of the aorta was performed to confirm disease progression.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>In this comparative study, within the same cohort, <sup>18</sup>F-NaF PET detected atherosclerotic calcification earlier than microCT. At both 1 and 3 h post-injection (p.i.), calcified lesions were clearly detected by <sup>18</sup>F-NaF with a six-fold higher signal in <i>Apoe</i><sup>-/-</sup> compared to WT mice. Interestingly, <sup>18</sup>F-NaF signal peaked at week 18, whereas aortic CT signal progressively increased with a 13-, 16-, and 29-fold at 15, 18, and 20 weeks, respectively. <sup>18</sup>F-FDG arortic accumulation at weeks 12 and 15, were significantly greater in <i>Apoe</i> <sup>−/−</sup> mice than WT control when images were acquired at 5 h but not at 3 h p.i.. In contrast to histological analysis, at ≥ 16 weeks where inflammation is significantly elevated, <sup>18</sup>F-FDG was equivalent in <i>Apoe</i><sup>−/−</sup> and WT control mice and significantly reduced with disease progression.</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusions</h3><p>Our results show that <sup>18</sup>F-NaF PET and <sup>18</sup>F-FDG PET are sensitive imaging modalities for the early detection of atherosclerotic lesions. However, both <sup>18</sup>F-NaF PET and high-resolution microCT prove to be effective methods for monitoring late-stage and progressive disease.</p>\",\"PeriodicalId\":11909,\"journal\":{\"name\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"volume\":\"7 1\",\"pages\":\"\"},\"PeriodicalIF\":8.6000,\"publicationDate\":\"2025-04-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00259-025-07276-1\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07276-1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

合理检测动脉粥样硬化对于管理和预防危及生命的心血管事件至关重要。尽管非侵入性成像方式,如18f -氟化钠(18F-NaF)、18f -氟脱氧葡萄糖(18F-FDG) PET和CT,可以显示动脉粥样硬化的明显特征,但尚未有单一的多队列研究对其优势和局限性进行质疑。因此,我们专注于确定在疾病进展的不同阶段可视化动脉粥样硬化的最佳方法。方法在本研究中,6周龄的雄性ApoE缺陷小鼠(ApoE−/−)被置于高胆固醇饮食12-20周,以诱导钙化动脉粥样硬化疾病。以年龄匹配的野生型(WT) C57BL/6雄性小鼠为对照组。小鼠在开始各自的饮食后的12、15、18和20周进行成像。为了跟踪钙化动脉粥样硬化病变的进展,在体内的每个时间点,在静脉注射示踪剂1小时和3小时后获取18F-NaF显微pet /CT图像。在另一个单独的队列中,在静脉注射示踪剂后3和5小时获得体内18F-FDG PET/CT图像,以跟踪由于动脉粥样硬化病变形成的进展性炎症。所有小鼠获得高分辨率微ct图像,以显示主动脉钙化。每次成像后,从每组中选取一个亚组(n = 3)实施安乐死,并对主动脉进行组织学分析以确认疾病进展。结果在这项比较研究中,在同一队列中,18F-NaF PET比显微ct更早发现动脉粥样硬化钙化。在注射后1和3小时(p.i), 18F-NaF明显检测到钙化病变,Apoe-/-的信号比WT小鼠高6倍。有趣的是,18F-NaF信号在第18周达到峰值,而主动脉CT信号在15、18和20周分别增加了13倍、16倍和29倍。在第12周和第15周,Apoe−/−小鼠的18F-FDG在动脉积聚显著高于WT对照组,在第5小时获得图像,而在第3小时获得图像。与组织学分析相反,在炎症显著升高的≥16周时,Apoe−/−和WT对照小鼠的18F-FDG是相同的,并且随着疾病进展而显著降低。结论18F-NaF PET和18F-FDG PET是早期发现动脉粥样硬化病变的灵敏成像方式。然而,18F-NaF PET和高分辨率显微ct被证明是监测晚期和进展性疾病的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis

Rationale

Detection of atherosclerosis is essential to the management and prevention of life-threatening cardiovascular events. Although non-invasive imaging modalities, such as 18F-sodium fluoride (18F-NaF), 18F-fluorodeoxyglucose (18F-FDG) PET, and CT, visualize distinct hallmarks of atherosclerosis, there has yet to be a singular multi-cohort interrogation of their strengths and limitations. Thus, we focused on identifying the optimal approach for visualizing atherosclerosis at different stages of disease progression.

Methods

In this study, 6-week-old, male, ApoE deficient mice (Apoe−/−) were placed on a high cholesterol diet for 12–20 weeks to induce calcific atherosclerotic disease. Age-matched, male, wildtype (WT) C57BL/6 mice fed with regular chow served as the control group. Mice were imaged at 12, 15, 18, and 20 weeks after starting their respective diets. To follow the progression of calcified atherosclerotic lesions, at each time point, in vivo, 18F-NaF microPET/CT images were acquired 1 h and 3 h post tracer i.v. injection. In a separate cohort, in vivo 18F-FDG PET/CT images were acquired at 3 and 5 h post tracer i.v. injection to follow inflammation as a result of progressive atherosclerotic lesion formation. High-resolution microCT images were acquired for all mice to visualize aorta calcification. After each imaging session, a subset (n = 3) was euthanized from each group and histological analysis of the aorta was performed to confirm disease progression.

Results

In this comparative study, within the same cohort, 18F-NaF PET detected atherosclerotic calcification earlier than microCT. At both 1 and 3 h post-injection (p.i.), calcified lesions were clearly detected by 18F-NaF with a six-fold higher signal in Apoe-/- compared to WT mice. Interestingly, 18F-NaF signal peaked at week 18, whereas aortic CT signal progressively increased with a 13-, 16-, and 29-fold at 15, 18, and 20 weeks, respectively. 18F-FDG arortic accumulation at weeks 12 and 15, were significantly greater in Apoe −/− mice than WT control when images were acquired at 5 h but not at 3 h p.i.. In contrast to histological analysis, at ≥ 16 weeks where inflammation is significantly elevated, 18F-FDG was equivalent in Apoe−/− and WT control mice and significantly reduced with disease progression.

Conclusions

Our results show that 18F-NaF PET and 18F-FDG PET are sensitive imaging modalities for the early detection of atherosclerotic lesions. However, both 18F-NaF PET and high-resolution microCT prove to be effective methods for monitoring late-stage and progressive disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
9.90%
发文量
392
审稿时长
3 months
期刊介绍: The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信